摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1H-蝶啶-2-硫酮 | 16878-76-5

中文名称
1H-蝶啶-2-硫酮
中文别名
——
英文名称
2-mercaptopteridine
英文别名
mercaptopteridine;1H-pteridine-2-thione;2-Mercapto-pteridin;Pteridine-2-thiol;1H-pteridine-2-thione
1H-蝶啶-2-硫酮化学式
CAS
16878-76-5
化学式
C6H4N4S
mdl
MFCD11109360
分子量
164.191
InChiKey
DAAQPMSPBHQGQA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    205°C
  • 沸点:
    282.5±23.0 °C(Predicted)
  • 密度:
    1.3717 (rough estimate)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.2
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    82.3
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2933990090

SDS

SDS:0d23e55e8a8f5e9cf7641095a7f1fad7
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Linker-Based Lecithin Microemulsion Delivery Vehicles
    申请人:Acosta-Zara Edgar Joel
    公开号:US20080139392A1
    公开(公告)日:2008-06-12
    The present invention relates to biocompatible microemulsion systems designed for controlled release drug delivery applications formulated with phospholipids such as lecithin (surfactant), a lipophilic additive (linker) containing 9 or more carbons in their alkyl group and hydrophilic-lipophilic balance (HLB) of 5 or less, and a surfactant-like hydrophilic additive (linker) containing between 6 to 9 carbon atoms in their alkyl tail. The combination of linkers and phospholipids produce formulations capable of delivering high concentrations of poorly soluble drugs into epithelial tissue using low surfactant concentrations, with minimum cytotoxic side effects.
    本发明涉及生物相容性微乳液系统,用于控制释放药物的应用,其配方包括磷脂类物质,如卵磷脂(表面活性剂),含有9个或更多碳原子的疏水性添加剂(连接剂),以及亲水-疏水平衡(HLB)为5或更低的类表面活性剂的亲水性添加剂(连接剂),连接剂和磷脂类物质的组合可产生配方,能够使用低表面活性剂浓度将高浓度的难溶性药物输送到上皮组织中,且具有最小的细胞毒性副作用。
  • Substituted mercapto acid amides, process for their preparation, pharmaceutical composition containing same and their use
    申请人:Merck & Co., Inc.
    公开号:EP0001989A1
    公开(公告)日:1979-05-30
    Substituted mercapto acid amides are prepared, and are useful as immunoregulants for correcting an imbalance of immune homeostasis, particularly as immunostimulants in the treatment of autoimmune and immune deficient diseases and disorders.
    所制备的取代巯基酸酰胺可作为免疫调节剂用于纠正免疫平衡失调,特别是作为免疫刺激剂用于治疗自身免疫性和免疫缺陷性疾病和紊乱。
  • Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
    申请人:Platform Brightworks Two, Ltd.
    公开号:US10028949B2
    公开(公告)日:2018-07-24
    There may be provided compositions of lipophilic pharmaceutical agents with improved solubility and stability. For example, there may be provided a non-aqueous composition that comprises a lipophilic pharmaceutical agent, and an amphiphilic polymeric solvent such as PEG400 but essentially free of organic solvents and non-solubilized particles. The composition may be further diluted with a desired aqueous diluent such as an infusion fluid for parenteral administration to a subject such as a human. The compositions may be useful for the treatment for diseases or conditions that are sensitive to lipophilic agents, such as infectious diseases, malignant or autoimmune diseases.
    可提供具有更好溶解性和稳定性的亲脂性药剂组合物。例如,可以提供一种非水性组合物,其中包括亲脂性药剂和两亲性聚合物溶剂(如 PEG400),但基本上不含有机溶剂和非增溶颗粒。该组合物可进一步用所需的水性稀释剂稀释,如输液,用于人等受试者的非肠道给药。该组合物可用于治疗对亲脂性制剂敏感的疾病或病症,如传染性疾病、恶性或自身免疫性疾病。
  • Compositions and methods for organ specific delivery of nucleic acids
    申请人:The Board of Regents of the University of Texas System
    公开号:US11229609B2
    公开(公告)日:2022-01-25
    The present disclosure provides compositions which shown preferential targeting or delivery of a nucleic acid composition to a particular organ. In some embodiments, the composition comprises a steroid or sterol, an ionizable cationic lipid, a phospholipid, a PEG lipid, and a permanently cationic lipid which may be used to deliver a nucleic acid.
    本公开提供的组合物可将核酸组合物优先靶向或递送至特定器官。在某些实施方案中,组合物包含可用于递送核酸的类固醇或甾醇、可电离阳离子脂质、磷脂、PEG 脂质和永久阳离子脂质。
  • Albert et al., Journal of the Chemical Society, 1954, p. 3832,3833
    作者:Albert et al.
    DOI:——
    日期:——
查看更多